Literature DB >> 11392883

Decreased CD10 expression in grade III and in interfollicular infiltrates of follicular lymphomas.

C Eshoa1, S Perkins, B Kampalath, V Shidham, M Juckett, C C Chang.   

Abstract

CD10 expression in various grades and interfollicular infiltrates of follicular lymphoma (FL) has not been well documented. Immunohistochemical staining for CD10 (clone 56C6) was performed on paraffin-embedded tissue from 26 cases of classic FL. Negative or weak expression of CD10 was more frequent in grade III (5/6 [83%]) than in grade I FLs (3/15 [20%]). CD10+ interfollicular infiltrates were present in 16 cases. Six (38%) of 16 cases showed that CD10 expression was strong or moderate in follicular areas but weak or negative in interfollicular infiltrates. Our results suggest that CD10 expression is frequently weak to negative in grade III and in interfollicular infiltrates of FLs. Therefore, lack of CD10 expression on small specimens, such as from needle core biopsy or fine-needle aspiration, does not preclude the possibility of a diagnosis of FL. Furthermore, lack of CD10 expression in diffuse large B-cell lymphoma does not exclude the possibility that the neoplastic lymphocytes are of follicle center cell origin.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11392883     DOI: 10.1309/B6MK-J7NF-A6JP-X56K

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  10 in total

1.  Prognostic significance of B-cell differentiation genes encoding proteins in diffuse large B-cell lymphoma and follicular lymphoma grade 3.

Authors:  Ana Borovecki; Petra Korać; Marin Nola; Davor Ivanković; Branimir Jaksić; Mara Dominis
Journal:  Croat Med J       Date:  2008-10       Impact factor: 1.351

2.  The efficacy of HGAL and LMO2 in the separation of lymphomas derived from small B cells in nodal and extranodal sites, including the bone marrow.

Authors:  Sheren F Younes; Andrew H Beck; Robert S Ohgami; Izidore S Lossos; Ronald Levy; Roger A Warnke; Yasodha Natkunam
Journal:  Am J Clin Pathol       Date:  2011-05       Impact factor: 2.493

3.  Pattern of MEF2B expression in lymphoid tissues and in malignant lymphomas.

Authors:  Dóra Krenács; Zita Borbényi; Judit Bedekovics; Gábor Méhes; Enikő Bagdi; László Krenács
Journal:  Virchows Arch       Date:  2015-06-19       Impact factor: 4.064

4.  Immunoarchitectural patterns in follicular lymphoma: efficacy of HGAL and LMO2 in the detection of the interfollicular and diffuse components.

Authors:  Sheren F Younes; Andrew H Beck; Izidore S Lossos; Ronald Levy; Roger A Warnke; Yasodha Natkunam
Journal:  Am J Surg Pathol       Date:  2010-09       Impact factor: 6.394

5.  Nodal Follicular Lymphomas: A Clinicopathological Study from a Tertiary Care Centre in South India.

Authors:  Divya Supari; Anuradha Ananthamurthy
Journal:  Indian J Hematol Blood Transfus       Date:  2015-11-02       Impact factor: 0.900

Review 6.  Primary follicular lymphoma of the testis in childhood: an entity with peculiar clinical and molecular characteristics.

Authors:  S A Pileri; E Sabattini; P Rosito; P L Zinzani; S Ascani; G Fraternali-Orcioni; B Gamberi; M Piccioli; D Vivenza; B Falini; G Gaidano
Journal:  J Clin Pathol       Date:  2002-09       Impact factor: 3.411

7.  Comparison of germinal center markers CD10, BCL6 and human germinal center-associated lymphoma (HGAL) in follicular lymphomas.

Authors:  Gaia Goteri; Guendalina Lucarini; Antonio Zizzi; Antonello Costagliola; Federica Giantomassi; Daniela Stramazzotti; Corrado Rubini; Pietro Leoni
Journal:  Diagn Pathol       Date:  2011-10-11       Impact factor: 2.644

8.  Biomarkers for Risk Stratification in Patients With Previously Untreated Follicular Lymphoma Receiving Anti-CD20-based Biological Therapy.

Authors:  Aliyah R Sohani; Matthew J Maurer; Sharmila Giri; Brandelyn Pitcher; Amy Chadburn; Jonathan W Said; Nancy L Bartlett; Myron S Czuczman; Peter Martin; Cara A Rosenbaum; Sin-Ho Jung; John P Leonard; Bruce D Cheson; Eric D Hsi
Journal:  Am J Surg Pathol       Date:  2021-03-01       Impact factor: 6.298

9.  Smad1 expression in follicular lymphoma.

Authors:  Jai Hyang Go
Journal:  J Pathol Transl Med       Date:  2015-05-15

10.  Significance of abnormal 53BP1 expression as a novel molecular pathologic parameter of follicular-shaped B-cell lymphoid lesions in human digestive tract.

Authors:  Thi My Hanh Luong; Katsuya Matsuda; Daisuke Niino; Hirokazu Kurohama; Masahiro Ito; Masahiro Nakashima
Journal:  Sci Rep       Date:  2021-02-04       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.